AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting
/PRNewswire/ -- AbbVie (NYSE: ABBV) will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of...
United States Mohamed Zaki Obinutuzumab Clb Venetoclax Rituximab Ven Janssen Biotech Inc Abbvie Company
Source: prnewswire.com